IP Library Granted Patent US 7,605,260
Granted Patent B2
US 7,605,260 · App. 10/565,105 · Granted Oct 20, 2009

Process for producing imide compound

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,605,260
App. No.
10/565,105
Granted
Oct 20, 2009
Kind
B2
Abstract

The present invention provides an excellent industrial process for producing an imide compound hydrochloride. The process for producing an imide compound hydrochloride of the formula (2): or an enantiomer thereof, which comprises treating a compound of the formula (1): or an enantiomer thereof with an aqueous hydrochloric acid solution in a hydrophilic solvent, followed by crystallizing the resultant.

Claims (5)

1. A process for producing an imide compound hydrochloride of the formula (2):

or an enantiomer thereof,

which comprises treating a compound of the formula (1):

or an enantiomer thereof with 1.8 to 5.0% aqueous hydrochloric acid solution in acetone, crystallizing the resultant hydrochloride of the formula (2), and isolating the crystallized hydrochloride of the formula (2).

2. The process for producing the imide compound hydrochloride according to claim 1 , wherein the aqueous hydrochloric acid solution is a 3.0-5.0% aqueous hydrochloric acid solution.

Assignments (4)
CHANGE OF NAME Recorded Nov 21, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 061972/0730 →
CHANGE OF NAME Recorded Oct 17, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 034014/0418 →
CHANGE OF NAME Recorded Oct 2, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033887/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2006
From: KAKIYA, YUZO; ODA, MAYUMI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 017473/0130 →